Vis enkel innførsel

dc.contributor.authorCanoy, D.
dc.contributor.authorHarvey, Nicholas C.
dc.contributor.authorPrieto-Alhambra, Daniel
dc.contributor.authorCooper, Cyrus
dc.contributor.authorMeyer, H.E.
dc.contributor.authorÅsvold, B.O.
dc.contributor.authorNazarzadeh, M.
dc.contributor.authorRahimi, Kazem
dc.identifier.citationOsteoporosis International. 2021, 1-12.en_US
dc.description.abstractBlood pressure and bone metabolism appear to share commonalities in their physiologic regulation. Specific antihypertensive drug classes may also influence bone mineral density. However, current evidence from existing observational studies and randomised trials is insufficient to establish causal associations for blood pressure and use of blood pressure–lowering drugs with bone health outcomes, particularly with the risks of osteoporosis and fractures. The availability and access to relevant large-scale biomedical data sources as well as developments in study designs and analytical approaches provide opportunities to examine the nature of the association between blood pressure and bone health more reliably and in greater detail than has ever been possible. It is unlikely that a single source of data or study design can provide a definitive answer. However, with appropriate considerations of the strengths and limitations of the different data sources and analytical techniques, we should be able to advance our understanding of the role of raised blood pressure and its drug treatment on the risks of low bone mineral density and fractures. As elevated blood pressure is highly prevalent and blood pressure–lowering drugs are widely prescribed, even small effects of these exposures on bone health outcomes could be important at a population level.en_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.titleElevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directionsen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.source.journalOsteoporosis Internationalen_US

Tilhørende fil(er)


Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal